The health care sector today just went positive for 2009, making it the only major industry group to currently be in the green for this young year. The Health Care Select Sector SPDR ETF is higher today on the back of better-than-expected results from Merck and Schering-Plough . Credit ok earnings, buyout activity (Pfizer target Wyeth is the sector's top performer) and investors crowding into a defensive sector to heal their portfolio's wounds for 2009's outperformance.
But will this sector's good fortune last? Brown Brothers Harriman's Andrew Burkly, a technical analyst and frequent Fast Money guest, thinks so. The sector has momentum and strong support at its 50-day moving average, a common metric used by chart-watchers.
"We continue to like the S&P 500 Health Care Sector based on its technical profile and defensive characteristics," writes Burkly, in a note to clients this morning.
An even better way to play the trends unfolding in the space is to bet on biotech directly, according to FM traders Pete Najarian and Karen Finerman. They've been recommending the Biotech SPDR ETF, with top holdings like Amgen and Genentech . Genentech got some positive news today related to its Avastin lung cancer drug.
Got something to say? Send us an e-mail at email@example.com and your comment might be posted on the Rapid Recap! If you'd prefer to make a comment but not have it published on our website send your message to firstname.lastname@example.org.